Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,976–4,000 of 7,816 matching trials · page 160 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Chocolate and Physical Exercise to Reduce Malnutrition in Pre-dementia Aged People NCT05343611 Combination of High Protein Diet and Physical Exercise protocol; HP... Runs in: Italy · 4 sites |
NA other |
UNKNOWN | 102 | Massimo Venturelli, PhD OTHER |
2023-06-23 |
|
Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients NCT03435861 VX-745; placebo Runs in: France · 1 site |
PHASE2 other |
COMPLETED | 34 | University Hospital, Toulouse OTHER |
2023-06-22 |
|
Our Care Wishes - Dementia NCT05033262 Our Memory Care Wishes Runs in: United States · 1 site |
NA other |
COMPLETED | 14 | University of Pennsylvania OTHER |
2023-06-22 |
|
Impact of Apathy on Caregiving in HD. Version 1 NCT05913154 Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 20 | University of East Anglia OTHER |
2023-06-22 |
|
Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease NCT01539031 E2020; E2020 Runs in: Japan · 54 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 351 | Eisai Co., Ltd. INDUSTRY |
2023-06-18 |
|
Development and Evaluation of the DEA App NCT03819816 DEA-App; Standard Information group Runs in: Austria · 2 sites |
NA other |
COMPLETED | 36 | Valentin Ritschl OTHER |
2023-06-18 |
|
Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE) NCT05124561 Recombinant COVID-19 vaccine (adenovirus type 5 vector) for Inhalat... |
PHASE3 other |
WITHDRAWN | 0 | CanSino Biologics Inc. INDUSTRY |
2023-06-18 |
|
Assessment of Clinical Trial Experiences of Alzheimer's Disease Patients NCT05672732 |
NA other |
UNKNOWN | 500 | Power Life Sciences Inc. INDUSTRY |
2023-06-18 |
|
A Biomarker-directed Study of XPro1595 in Patients With Alzheimer's NCT03943264 XPro1595 Runs in: Australia · 5 sites |
PHASE1 other |
COMPLETED | 20 | Inmune Bio, Inc. INDUSTRY |
2023-06-15 |
|
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects NCT04141150 [18F]APN-1607 Runs in: United States · 3 sites |
PHASE2 other |
UNKNOWN | 130 | APRINOIA Therapeutics, LLC INDUSTRY |
2023-06-15 |
|
At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer's Disease and Their Caregiver's NCT04512040 At-Home Yoga Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | Palo Alto Veterans Institute for Research OTHER |
2023-06-15 |
|
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above NCT04526990 Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector); Placebo Runs in: Argentina; Chile; Mexico; Pakistan; Russia · 74 sites |
PHASE3 other |
COMPLETED | 44,247 | CanSino Biologics Inc. INDUSTRY |
2023-06-15 |
|
A Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents NCT05169008 Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector); R... Runs in: Chile · 2 sites |
PHASE3 other |
TERMINATED | 91 | CanSino Biologics Inc. INDUSTRY |
2023-06-15 |
|
A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants NCT05344989 APNmAb005; Placebo Runs in: United States · 1 site |
PHASE1 other |
UNKNOWN | 40 | APRINOIA Therapeutics, LLC INDUSTRY |
2023-06-15 |
|
Apathy in Dementia Methylphenidate Trial 2 NCT02346201 Methylphenidate; Placebo Runs in: Canada; United States · 10 sites |
PHASE3 other |
COMPLETED | 200 | Johns Hopkins Bloomberg School of Public Health OTHER |
2023-06-13 |
|
MRI Study of Blood-brain Barrier Function in CADASIL NCT05902039 MRI Runs in: China · 1 site |
NA other |
UNKNOWN | 100 | Peking University First Hospital OTHER |
2023-06-13 |
|
A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease NCT04491006 ATH-1017; Placebo Runs in: Australia; United States · 13 sites |
PHASE2 other |
COMPLETED | 77 | LeonaBio INDUSTRY |
2023-06-12 |
|
Intervention Effect of Yizhi Baduanjin on Patients With Mild Cognitive Impairment NCT05899777 Yizhi Baduanjin |
NA other |
UNKNOWN | 100 | Shanghai University of Traditional Chinese Medicine OTHER |
2023-06-12 |
|
Linus Health CDS Retrospective Validation Study NCT05900310 Core Cognitive Evaluation (CCE) Runs in: United States · 1 site |
NA other |
UNKNOWN | 40 | Linus Health, Inc. INDUSTRY |
2023-06-12 |
|
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study NCT02580305 SUVN-502; Placebo; Donepezil; Memantine Runs in: United States · 71 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 564 | Suven Life Sciences Limited INDUSTRY |
2023-06-09 |
|
Optimization of Blood Levels of 25(OH)-Vitamin D in African Americans NCT04939792 Vitamin D; Placebo; Vitamin D + L-cysteine; L-cysteine Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 165 | Louisiana State University Health Sciences Center Shreveport OTHER |
2023-06-08 |
|
SAMi Intervention Study to Evaluate Smartwatch Interventions in Persons With MCI and Dementia NCT05885620 drinking reminder and cognitive task (smartwatch-based application) Runs in: Germany · 1 site |
NA other |
COMPLETED | 40 | University of Rostock OTHER |
2023-06-07 |
|
Effect of Transcranial Random Noise (tRNS) for Early Alzheimer's Disease NCT05891444 High frequency transcranial random noise; Sham high frequency trans... Runs in: China · 1 site |
NA other |
UNKNOWN | 40 | Anhui Medical University OTHER |
2023-06-07 |
|
Effects of Hydrogen Gas Inhalation on Adults of Various Ages NCT05891938 H2 gas inhalation Runs in: South Korea · 2 sites |
NA other |
COMPLETED | 54 | Wonju Severance Christian Hospital OTHER |
2023-06-07 |
|
Enhancing Consent for Alzheimer's Research NCT00453544 Enhanced Consent Procedure; Routine Consent Procedure Runs in: United States · 1 site |
NA other |
COMPLETED | 252 | University of California, San Diego OTHER |
2023-06-06 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial